TAILORx results eliminate uncertainty around intermediate results and show that most patients may not benefit from chemotherapy1,2
The largest randomised adjuvant breast cancer treatment trial ever conducted
TAILORx was independently led by ECOG-ACRIN Cancer Research Group with sponsorship from the National Cancer Institute. Participating cancer research groups included the Alliance for Clinical Trials in Oncology, NCIC-Clinical Trials Group, NRG Oncology, and SWOG.
TAILORX: TRANSFORMING THE TREATMENT OF BREAST CANCER
Learn more about the TAILORx trial in the video below
Largest ever adjuvant breast cancer treatment clinical trial results - 5-year outcomes, 9-year outcomes and 12-year results5: